BB&T Capital Downgrades Amedisys (AMED) to Underweight
Tweet
Share
E-mailGet Alerts AMED Hot Sheet
Price: $100.99 --0%
Rating Summary:
6 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Rating Summary:
6 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
BB&T Capital downgraded Amedisys (NASDAQ: AMED) from Hold to Underweight.
For more ratings news on Amedisys click here and for the rating history of Amedisys click here.
Shares of Amedisys closed at $14.56 yesterday.
For more ratings news on Amedisys click here and for the rating history of Amedisys click here.
Shares of Amedisys closed at $14.56 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GLJ Research Downgrades Fluence Energy Inc. (FLNC) to Hold
- RBC Capital Downgrades Temple & Webster Group Ltd (TPW:AU) to Sector Perform
- UBS Downgrades Merck (MRK) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
BB&T Capital MarketsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
